Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.

Shares of Quest Diagnostics Inc. DGX slid 3.78% to $164.18 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 5.97% to 5,074.08 ...

The most recent lawsuit is from winter 2024, when the California attorney general announced a $5 million settlement with ...

Quest Diagnostics Inc. closed 4.61% short of its 52-week high of $178.87, which the company reached on March 10th.

Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...

The price of the deal was disclosed for the first time in bond filings, showing how it helped flip a net operating loss last ...

Quest Diagnostics Incorporated's ( NYSE:DGX ) dividend will be increasing from last year's payment of the same ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

I had a very NASTY MANNERED technician. I believe she cared more about her makeup that morning than her patient's feelings. She shhhhhed me in mid-sentence and I had to remind her to say, "please ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a new solution aimed at broadening access to human papillomavirus (HPV) screening to help identify women who ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

Quest Diagnostics teamed up with Google Cloud. The collaboration seeks to deliver new AI capabilities — including predictive ...